фиброза печени у больных с хроническим. гепатитом С на основе комбинаций геномных. Методом множественных ранговых сравнений выявлен более высокий темп про-цессов фиброзирования в группе 3 по сравнению с груп-пами 1 (р 0,002) и 2 (р 0,021).


Чтобы посмотреть этот PDF файл с форматированием и разметкой, скачайте его и откройте на своем компьютере.
       J  Q �  
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
1
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
  
PECAFP GC 6B8
!"#
�� - ?I I   -  



 7 ? 2 6~epatitis } [irus- ~}[8-   -   
    I  ? 7 O

ATR1 1166 A`C
C~BA 242

 ? 7 O
#+'1
1!) $ 
  
9$  &  
@  @       )!  
    I  ?    
�  5!2- ??I    7  � O
 $5$% % $ 
0& *   *2$%
+ " $ 
�  -       ? @ 
   7 -  ? 7    ? 7   
 "  + 
�7  ?   ?I  7  
S\mp wU\ Zlood qini ]it     
S\cube 6S\YU mb~- !  8.
 ? @  ?    ? 
@  H &!
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
2
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
       J  Q �  
  ? J ?  !3%  %  )O
 7           O
 ".). 2  )    I - 
    6?  E  CE O
 ) $!
�   
   ?    ? 7  Ttatistica AC.
7 O   )  . #     O
\         7 ?   O� -         ? ?      7 \U`[\     �. #    ?   ?   E E ?           0 O
� -     ?     
#8$/7+!+1
9  $ 
6G-B8 � ^M. $  FG 6HL-M8 ?   
�   5!2 6^H ? qYV\[S_8.  
�� 2      7 @  -           7 ??       I
("8!&J"(8 *#'/#16J"(8 1+(16
 6n8-
=  
EC-H 6AA8
MF-D 6EM8
BH-A 6HA8
 - )HG-DAH-DFC-AAM-CC-MDL
   @  - )EC-BAE-CMA-EAA-LC-CCC
#    @  - )EG-EAA-HAD-CMAC-ADC-CCC
! ?   6n8-
GB-A 6MF8
AD-B 6D8
GF-C 6MB8
AB-G 6L8
C-CBH
,  
,  P
!   @
%?     
1 P   7
)  � 
# 7
BA-A
EH-A 6AM8
A-D 6A8
MA-L 6EC8
A-B 6A8
A-FD 6A8
2� @  6n8-
FG-H 6MA8
G-H 6H8
G-H 6H8
EG-L 6AF8
AG-E 6AA8
G-L 6F8
(1- $P-    6 8HB-G 6MA-CGM-C8BF 6HA-FDA-F8C-CHA
21- $P-    6 8MD-D 6ED-CBL-C8FD 6HA-EACH-F8C-CAC
! 6n8- M-G 6E8H-G 6M8A-CCC
 7�  6n8- EL-C 6AH8MA-G 6AD8C-LMH
   E- O   )   M- tO   2I 
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
3
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
  
PECAFP GC 6B8
�?-    ?       ~}[O
1?   ~}[ , 6 ?    7 ? O
@  - ?   1. oynard  . AK
#//#/7 j #+"0J"(8 *#'/#16 \n_, {J"(8 1+(16 \n_, {
LL-D 6HL8GL-A 6FC8
C-AHH
}AA-A 6B8EA-D 6AH8
}}C-C 6C8C-C 6C8
C~BA 242 C`T
}}HB-M 6EF8HB-D 6MC8
C-ADG
}VFC 6EG8HC-H 6EB8
VVM-G 6E8AE-F 6L8
}}Q}VDB-M 6FE8LG-F 6FB8C-ACG
BF-G 6GA8HD-E 6BM8
C-CAE
\MH-M 6MG8FC-L 6BF8
HE-B 6EM8EB-B 6AG8
C-CHA
\HB-M 6EF8HF-M 6ED8
\\AA-A 6B8EL-A 6AL8
Q\LL-D 6HL8GA-M 6HB8C-CEH
\Q\\FG-H 6MA8GM-H 6HG8C-CLC
qBA-A
6BB8HH-F 6FG8
C-CAM
VML-D 6HE8FF-F 6GA8
qqHH-H 6EH8AL-G 6AE8
C-CAC
qVMM-M 6AL8FA-B 6MM8
VVEE-E 6AE8ED-G 6AD8
qVQVVFF-B 6MC8LA-M 6FE8C-CCF
FM-G 6ED8MG-F 6EH8
1MF-E 6AD8HF-M 6ED8
11AA-A 6B8AG-E 6AA8
1Q11HB-M 6EF8BE-F 6HC8C-CDB
ITGA2 807 C`T
}}MF-E 6AD8MF-D 6EM8
C-AHF
}VML-D 6EA8FA-B 6MM8
VVEF-D 6AH8AE-F 6L8
}}Q}VGH-A 6HC8LG-F 6FB8C-CDF
PAI -675 5G`4G
FFMA-F 6AG8AG-E 6AA8
C-ABH
FHHE-B 6EM8FB-E 6MB8
HHEF-D 6AH8EB-B 6AG8
FHQHHBL-F 6MG8LE-L 6FM8C-CLH
   E.
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
4
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
       J  Q �  
?       68  7 ? 638 ? @
?  OBV
0 " !$%" $ 
� 6. E8.
?  OBV ?
C-CAE8 
? Q\ 6EL-A ?  AA-A- C-CEH . A8.
�       O
C-CAC
. E8.   7- ?    7 ?
� C-CAC8.    
? O
C-CCA8- . . ?    7

 J O
ATR1 1166 A`C
?       68  7 ? 638 ? @
?  )EMF1
�� 2  @      ? @    O
#
//#/7 j
#+"0
#'. -"(8!j5',
*#'"!! \&!(+"/"_
C-AM 6C-CGC-EE8
C-HCD
}C-AB 6C-ACC-EA8
C~BA 242 C`T
}}C-AH 6C-CLC-EC8
}VC-AE 6C-CGC-EF8
VVC-EE 6C-AMC-MM8
}}Q}VC-AM 6C-CGC-EA8C-CAL
}VQVVC-AM 6C-CLC-EG8C-BEG
ITGA2 807 C`T
}}C-AH 6C-ACC-EF8
C-CLH
}VC-AF 6C-CDC-EE8
VVC-CD 6C-CBC-AG8
}}Q}VC-AF 6C-ACC-EE8C-CEL
}VQVVC-AF 6C-CGC-EA8C-EGM
C-AE 6C-CGC-AG8
C-ECH
1C-AF 6C-ACC-EE8
11C-EA 6C-CDC-ED8
Q1C-AM 6C-CLC-EA8C-EFF
1Q11C-AB 6C-CDC-EM8C-CDC
PAI -675 5G`4G
FFC-AA6C-CGC-EC8
FHC-AF 6C-ACC-EE8
HHC-AH 6C-CBC-EE8
FFQFHC-AH 6C-CDC-EE8C-BHE
FHQHHC-AF 6C-CDC-EE8C-ECH
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
5
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
  
PECAFP GC 6B8
� C-AF8   I 7 ??  O
      7 ? ? @    
C~BA 242 C`T
ITGA2 807
PAI -675 5G`4G
�   7 ??       O
�  ? 7     @ .     ?  
��  @  6I    -     .
���@ P7- . M8. % -     7 ?
C~BA 242 C`T
�    I  
��@  ?   I     7 ? 22Q21
�6C-EE ?  C-AM . @ P7- C-CE . M8.  
�      ?        7
�   ? @ K -
��   I   @  6C-CD . @ P78 ?
�  I  ?     7 ?? 22Q21

C~BA 242 C`T
ITGA2 807
PAI -675 5G`4G

C~BA 242 T
PAI -675 4G
ITGA2 807 C
� C-CCA8. # 7 -   ? 



C-CAB8. )     
C-CCE8  E 6
C-CEA8. 2    
�        ? @  
I    I       
     7 ?    ?  
��        @ -  I  
�� 2  @      ? @     7 
68 
638
��� 3    7  7 ? @           ? 7     @ 
($00!9;
�2 OA
Y     
nALLBACAAFHACC
A-LFAH-LAAH-LAAA-AAAL-FEEC-MGD-EBG-HAA-LFC-CCC-CC
Y     
nCAFLAAAAAEAAAMA
C-CCA-FBG-LAAE-FCAG-ADAG-ADAL-GFAG-ADA-FBH-BDA-FB
Q !  
nADAMAHEAEEAGAFEMA
C-LFG-BMAA-CEAA-LBAG-LAL-BHAH-HAAE-GAA-BDE-FHC-LF
^      , .   `
q  
6 8
C-AC 6C-CGC-AF8C-AM 6C-CGC-E8C-AD 6C-AC-MM8
C-CAB
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
6
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
       J  Q �  
?  - A  ? 7- M    78. )  
���  @          
C-CCA8.



�� 7         @ 
C-CCCF8. %         7
C-CCA8- 7 ?? S  SS- SS
5$$%" $
$2'#"#
�7-   7   ?  
    ? 7  I O

 
]nodell8-   I 7 ?? ?      @O
�      ?      
��� 2  @          A 
��� 2  @          E 
($00!IIIIII
�2  
CAEMHFBGLDAC
nELACACAFAHABAMAHA
^      , .   `
nECMDMF
q   6 8C-CD 6C-CBC-AA8C-AH 6C-CGC-EE8C-E 6C-AC-MM8
C-CCA
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
7
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
  
PECAFP GC 6B8
  - ?   1. oynard  . A- 
�C-AHH8-           ?O
)   77 }}�      ? 
,       ? @ 7 
TNF -238 G`A
7I      7  O
   E 

?  
  @  O@ AC-   7 ? ?7 O
   @   ?I AA.     q.W. Zahr
AE.
 7  A�M.    ?   7  O
�     
 MC  8 AH. ,. ~amada  .  - 
�       -    .]. }onstantini 
. AF.

l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
8
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
       J  Q �  
���    @      O
ATR1 1166 /`^

  @  7     ?  
    -    @  
�     ? 7       O
C~BA 242 C`T
�   ? @ 7 . )  -
!? 7     
�I  - ?  ?     @  
?  
   7     .
    U. qaharshak  .  

    O
        ?  
�@     ?  EG. X.Y. \dinolfi  . ?O
C-CCA8-   
�     @  EL.      
?        7 ? ? @ BGG
�� 7 ??   5!2    
 ?   . q. right  . - 
C-CCH8 ED-
�  . oujolO_obert  . MC-      
   }. oulding  .- I   
  -    ?  MA.  O
�       @ 
C-CA8 ME.  
PAI-675 5G`4G

C-CE8.  @  7 7  6
PAI -675 5G`4G
 7 ? VV
1. \sselah  . ?    J?  EHC 7 
   , SV�\E  ?   
� C-CCCEH8 MM.  @ 7    
M�H.  -        ? 
2     7 ?    #,O
�  W. \rmendarizOZorunda  . ? -  O
PAI -675
�      ?  7 @ 
��  ?     ?   O
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
5
9
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
  
PECAFP GC 6B8
8 MG.
C~BA 242 C`T
ITGA2 807 C`T
PAI -675 5G`4G
�8-    ? 7     @ 
 ? .      ?I ?    
��   ?   7    -  
�   ?   ?    ? 7  5!2.
 ?       I [email protected]@  7  
@ -  7        MD.
�!&/[email protected]#"#

C~BA
PAI -6754G
ITGA2 807T
+@"& -"!"(!")
-/"&+ "+#(#
A. oynard V- _atziu [- Zenmanov |- wi qartino [- Zedossa - `poO
lon . ^ibrosis in patients ith chronic hepatitis }K detection and
significance.
Semin Liver Dis
. ECCCEC6A8KHGFF. doiK AC.ACFFPsO
E. �2 ()- "7  1)-   2)-   O
 1,- ,   1 - ) ,- 1  . 7  O
M. oell YY- YdardsOTmith }W- ~ay WX- }louston \w- }raO
ford w~- Thorthouse }- et al. ~ost genetic factors influence disease
progression in chronic hepatitis }.
Hepatology.
ECCCMA6H8KLELLMM.
doiK AC.ACFMPhe.ECCC.BEFM.
H. [idigal - ermer WW- {ein UU. olymorphisms in the interO
leukinOAC- tumor necrosis factorOalpha- and transforming groth
factorObetaA genes in chronic hepatitis } patients treated ith
interferon and ribavirin.
MB6E8KEGAEGG. doiK AC.
ACABP
TCABLOLEGL6CA8CCEHMOH.
F. ~amada ~- |atsuhashi ~- |ano ]- \risaa ]- Uakao ]- |ano q.
SnterleukinOAC promoter polymorphisms and liver fibrosis proO
gression in patients ith chronic hepatitis } in Wapan.
ECCMMD6M8KHFGL. doiK AC.
ACABPTCABLOLEGL6CM8CCEHBOC
B. _osen ~_- qc~utchison W- }onrad \W- Xentz WW- qarousek -
_ose TX- et al. Vumor necrosis factor genetic polymorphisms
and response to antiviral therapy in patients ith chronic hepatiO
tis }.
ECCEDG6M8KGAHGEC. doiK AC.
AAAAPj.AFGEO
CEHA.ECCE.CFFFE.x
G. Zarrett T- }ollins q- ]enny }- _yan Y- ]eane }`- }roe W. olyO
morphisms in tumour necrosis factorOalpha- transforming groth
factorObeta- interleukinOAC- interleukinOB- interferonOgamma- and
outcome of hepatitis } virus infection.
J Med Virol.
ECCMGA6E8KEAE
EAL. doiK AC.ACCEPjmv.ACHGE.
L. |ee XW- Vang W- ~errera W- ]aslo _\- van Xeeuen wW. Vumor
necrosis factor gene polymorphisms in patients ith cirrhosis from
chronic hepatitis } virus infection.
Genes Immun.
MDC. doiK AC.ACMLPsj.gene.BMBMBDB.
D. qigita ]- qiyazoe T- qaeda |- waikoku q- \biru T- eki V- et al.
}ytokine gene polymorphisms in Wapanese patients ith hepatitis
Z virus infectionOOassociation beteen V^ObetaA polymorphisms
and hepatocellular carcinoma.
ECCFHE6H8KFCFFAC. doiK
AC.ACABPj.jhep.ECCH.AA.CEB.
AC. Vakahara V- ^ukuyama |- Taito T- `gino V- qiyajima U- ]ohaO
se q. SlOA- Y^- and ~^ suppress the antiviral activity of interO
feron in primary monkey hepatic parenchymal cells.
Jpn J Infect Dis
ADDDFE6E8KHFL.
AA. Vian {- Then - ^eng ~- ao Z. SXOA beta attenuates S^UO
alpha betaOinduced antiviral activity and TV\VA activation in the
liverK involvement of proteasomeOdependent pathay.
ECCCABF6G8KMDFDMDBF. doiK AC.HCHDPjimmunol.ABF.G.MDFD.
AE. Zahr qW- Yl qenuay q- Zoeker ]~- qusholt Z- qanns q-
Xichtinghagen _. }ytokine gene polymorphisms and the susceptiO
bility to liver cirrhosis in patients ith chronic hepatitis }.
Liver Int.
ECCMEM6B8KHECHEF. doiK AC.
AAAAPj.AHGLOMEMA.ECCM.CCLGM.x.
AM. ~ennig ZW- ^rodsham \W- ~ellier T- ]napp T- |ee XW- right q-
et al. Snfluence of SXOAC_\ and SXOEE polymorphisms on outcome
of hepatitis } virus infection.
Liver Int.
ECCGEG6L8KAAMHAAHM. doiK
AC.AAAAPj.AHGLOMEMA.ECCG.C
AFAL.x.
AH. ]napp T- ~ennig ZW- ^rodsham \W- {hang X- ~ellier T- right q-
et al. SnterleukinOAC promoter polymorphisms and the outcome of
hepatitis } virus infection.
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
6
0
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1
       J  Q �  
    J 
  ).. ( 
AADADE- )- (  ? .- . MA-  ?. F-
eKmail:
slmRfbm.msu.ru
- ?   @  @       )!   ).. ( 
starostinaeeRgmail.com
  ).. ( 
AADADE- )- (  ? .- . MA-  ?. F-
eKmail:
yarovayaRmech.math.msu.su
�  ).. ( -   @       ? @        ? 7 ) O
? @ 7 @  !3%  %  )!)   ".). 2 
AADADE- )- (  ? .- . MA-  ?. F-
eKmail:
krasnovamguRyandex.ru
�   @  @       )!   ).. ( -     @ 7-
�    ? @         $.). 1  !3%  %  )!)   ".). 2 
AADADE- )- (  ? .- . MA-  ?. F-
eKmail:
moukhinOnephroRyandex.ru
   )!   ).. ( 
AADADE- )- (  ? .- . MA-  ?. F-
eKmail:
vatRfbm.msu.ru
).. ( 
AADADE- )- (  ? .- . MA-  ?. F-
eKmail:
infoRrector.msu.ru
AD. ang ~. Vransforming groth factorOA gene polymorphisms are
associated ith progression of liver fibrosis in }aucasians ith chronO
ic hepatitis } infection.
World J Gastroenterol.
ECCFAA6AM8KADED. doiK
AC.MGHLPjg.vAA.iAM.ADED.
EC. \lberti \- [ario \- ^errari \- istis _. _evie articleK chronic
hepatitis } O natural history and cofactors.
Aliment Pharmacol Ther.
ECCFEE6sE8KGHGL. doiK AC.
AAAAPj.AMBFOECMB.ECCF.CEBCE.x.
EA. Yrhardt \- qaschnerO`lberg \- qellenthin }- ]appert -
\dams `- wonner \- et al. ~^Y mutations and chronic hepatitis
}K ~BMw and }ELE| heterozygosity are independent risk factors
for liver fibrosis and cirrhosis.
ECCMML6M8KMMFMHE. doiK
AC.ACABPsCABLOLEGL6CE8CCHAFOH.
EE. eier \- _eugels q- eiskirchen _- asmuth ~Y- wietrich }-
Tieert Y- et al. }ommon heterozygous hemochromatosis gene
mutations are risk factors for inflammation and fibrosis in chronic
hepatitis }.
Liver Int.
ECCHEH6H8KELFEDH. doiK AC.
AAAAPj.AHGLO
MEMA.ECCH.CDEL.x.
EM. cal X- ~usa - {nojil [- ]ankov ]i. ~^Y }ELE| gene variant
is a risk factor for the progression to decompensated liver disease in
chronic viral hepatitis } subjects in the }zech population.
Res.
ECCGMG6D8KGHCGHG. doiK AC.
AAAAPj.ALGEOCMH.ECCG.CCAAL.x.
EH. Xebray - {ylberberg ~- ~ue T- oulet Z- }arnot ^- qartin T- et al.
Snfluence of ~^Y gene polymorphism on the progression and treatO
ment of chronic hepatitis }.
J Viral Hepat.
ECCHAA6E8KAGFALE. doiK
AC.ACHBPj.AMBFOELDM.ECCM.CCHLL.x.
EF. wost
alikovaO}imburova q- ]ratka ]- Ttransky W- utova S-
}ieslarova Z- ~orak W. Sron `verload and~^Yene qutations
in }zech atients ith }hronic Xiver wiseases.
Dis Markers.
ECAEME6A8KBFGE. doiK AC.AAFFPECAEPGDCHBH.
EB. ^orrest Y~- Vhorburn w- Tpence Y- `ien ]\- Snglis - Tmith }\-
et al. olymorphisms of the reninOangiotensin system and the severO
ity of fibrosis in chronic hepatitis } virus infection.
J Viral Hepat.
ECCFAE6F8KFADFEH. doiK AC.
AAAAPj.AMBFOELDM.ECCF.CCBMC.x.
EG. qaharshak U. Sncreased fibrosis progression rates in hepatitis }
patients carrying the prothrombin ECEAC\ mutation.
World J Gas-
ECAAAG6HF8KFCCG. doiK AC.MGHLPjg.vAG.iHF.FCCG.
EL. \dinolfi XY- Sngrosso w- }esaro - }immino \- w\nto q-
}apasso _- et al. ~yperhomocysteinemia and the qV~^_ }BGGV
polymorphism promote steatosis and fibrosis in chronic hepatitis }
patients.
Hepatology.
ECCFHA6F8KDDFACCM. doiK AC.ACCEPhep.ECBBH.
ED. right q. ^actor [ Xeiden polymorphism and the rate of fibroO
sis development in chronic hepatitis } virus infection.
Gut.
ECCMFE6L8KAECBAEAC. doiK AC.AAMBPgut.FE.L.AECB.
MC. oujolO_obert \- Zolle O|- oupon _- _obert \. ^actor [ Xeiden
as a risk factor for cirrhosis in chronic hepatitis }.
Hepatology.
ECCHMD6H8KAAGHAAGF. doiK AC.ACCEPhep.ECABB.
MA. oulding }- `Zrien }- Ygan ~- ~egarty WY- qcwonald -
`^arrelly }- et al. Vhe impact of inherited prothrombotic risk
factors on individuals chronically infected ith hepatitis } virus
from a single source.
J Viral Hepat.
ECCGAH6H8KEFFEFD. doiK
AC.AAAAPj.AMBFOELDM.ECCB.CCGDC.x.
ME. wik ]- de Zruijne W- Vakkenberg _Z- _oelofs WW- Vempelmans qW-
wijkgraaf q- et al. ^actor SSS [alMHXeu mutation accelerates
the development of fibrosis in patients ith chronic hepatitis Z and
Hepatology Research.
ECAEHE6G8KBBLBGB. doiK AC.
AAAAPj.ALGEO
CMH.ECAA.CCDBM.x.
MM. \sselah V- Ziche S- Xaurendeau S- aradis [- [idaud w- wegott }-
et al. Xiver ene Yxpression Tignature of qild ^ibrosis in atients
ith }hronic ~epatitis }.
Gastroenterology.
ECCFAED6B8KECBH
ECGF. doiK AC.ACFMPj.gastro.ECCF.CD.CAC.
MH. u - i |- |ao X- Tu X- |an |- Xi q- et al. enetO
ic polymorphism ofSV\E}LCGV can increase the risk of
ischemic stroke.
Int J Neurosci.
ECAHAEH6AA8KLHALFA. doiK
AC.MACDPCCECGHFH.ECAM.LGDGAL.
MF. \rmendrizOZorunda W- _incn \_- quozO[alle W^- ZuenoO
Vopete q- `regnO_omero Y- SslasO}arbajal q}- et al. ^ibrogenic
olymorphisms 6V^O- \SOA- \V8 in qexican atients ith
Ystablished Xiver ^ibrosis. otential }orrelation ith irfeniO
done Vreatment.
J Investig Med.
ECCLFB6G8KDHHDFM. doiK AC.EMAP
WSq.CbCAMe
MALALDAFAE.
MB. _ichardson qq. \ combination of genetic polymorphisms increasO
es the risk of progressive disease in chronic hepatitis }.
l
a
t

V
e
s
t
n
i
k

6
-
2
0
1
5

0
7
-
0
1
-
2
0
1
6
.
i
n
d
d



6
6
1
7
.
0
1
.
2
0
1
6



1
8
:
1
4
:
5
1

Приложенные файлы

  • pdf 44247552
    Размер файла: 293 kB Загрузок: 0

Добавить комментарий